LIVE QUOTE
Waters Corporation WAT
Healthcare · Medical - Diagnostics & Research · NYSE
$293.37
Market Cap$22.0B
P/E Ratio28.0
Beta1.20
Employees7,600

Investment Thesis

.

Competitive Moat

characterized by intangible assets, particularly in the form of proprietary technologies and regulatory compliance expertise that enhance the reliability of their products. The company's established brand reputation and high switching costs make it difficult for customers to transition to competitors, ensuring a durable advantage over the next 5-10 years. However, competitive threats from emerging players in mass spectrometry and chromatography could pressure market share, particularly if they introduce disruptive technologies at lower price points.

Growth Engine

Future revenue growth for Waters is anticipated to stem from several drivers, including an expanding TAM estimated at over $20 billion for analytical instruments in life sciences, increasing demand for drug development tools, and the growth of environmental testing markets. The company is strategically positioned to capitalize on geographic expansion into high-growth markets in Asia and continued innovation in product lines, particularly in mass spectrometry and liquid chromatography. Waters is currently gaining market share aided by its continuous investment in research and development, which underpins its organic growth strategy.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research WAT
Robinhood
$0 commission trades
Trade WAT
Webull
Extended-hours, options, charts
Trade WAT
TradingView
Advanced charts & screeners
Chart WAT
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-04-09, Waters Corporation (WAT) does not have a P/E ratio available, which makes it difficult to assess valuation compared to its peers in the healthcare sector. Investors should consider other factors such as market trends, company performance, and future growth potential before making a decision.
Waters Corporation does not currently pay a dividend, which may be a consideration for investors looking for income-generating stocks.
Waters Corporation operates in the healthcare sector, specifically within the medical diagnostics and research industry.
The market cap for Waters Corporation is not available as of the provided data. However, given its established presence in the healthcare sector, it is likely to be classified within the large-cap range.
Waters Corporation faces competition from companies such as Thermo Fisher Scientific, Agilent Technologies, and PerkinElmer, which also operate in the medical diagnostics and research industry.
FAQ generated 2026-04-09

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms